1. Home
  2. HRMY vs DNN Comparison

HRMY vs DNN Comparison

Compare HRMY & DNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$37.82

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Logo Denison Mines Corp (Canada)

DNN

Denison Mines Corp (Canada)

HOLD

Current Price

$2.69

Market Cap

2.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRMY
DNN
Founded
2017
1954
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Metals and Minerals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.5B
IPO Year
2020
1997

Fundamental Metrics

Financial Performance
Metric
HRMY
DNN
Price
$37.82
$2.69
Analyst Decision
Strong Buy
Analyst Count
9
0
Target Price
$51.33
N/A
AVG Volume (30 Days)
695.1K
39.0M
Earning Date
11-04-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
50.44
N/A
EPS
3.17
N/A
Revenue
$825,944,000.00
$3,493,456.00
Revenue This Year
$23.11
$197.29
Revenue Next Year
$16.15
$55.12
P/E Ratio
$12.04
N/A
Revenue Growth
21.13
23.35
52 Week Low
$25.52
$1.08
52 Week High
$40.93
$3.42

Technical Indicators

Market Signals
Indicator
HRMY
DNN
Relative Strength Index (RSI) 54.65 52.23
Support Level $37.12 $2.48
Resistance Level $39.60 $2.89
Average True Range (ATR) 1.15 0.14
MACD -0.38 0.01
Stochastic Oscillator 17.33 53.66

Price Performance

Historical Comparison
HRMY
DNN

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About DNN Denison Mines Corp (Canada)

Denison Mines Corp is a uranium exploration and development company focused on the Athabasca Basin region of northern Saskatchewan, Canada. The company holds a noteworthy 95% interest in its flagship Wheeler River Uranium Project, the undeveloped uranium project located in the infrastructure-rich eastern part of the Athabasca Basin. Additionally, it is involved in mine decommissioning and environmental services through its Closed Mines group, which manages the Elliot Lake reclamation projects and offers third-party post-closure mine care and maintenance services. The Company operates in two main segments: the Mining segment and the Corporate and Other segment. The majority of revenue is generated from the mining segment.

Share on Social Networks: